Long non-coding RNAs and cancer: a new frontier of translational research?
Tiling array and novel sequencing technologies have made available the transcription
profile of the entire human genome. However, the extent of transcription and the function of …
profile of the entire human genome. However, the extent of transcription and the function of …
Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics
T Shi, G Gao, Y Cao - Disease markers, 2016 - Wiley Online Library
Cancers have a high mortality rate due to lack of suitable specific early diagnosis tumor
biomarkers. Emerging evidence is accumulating that lncRNAs (long noncoding RNAs) are …
biomarkers. Emerging evidence is accumulating that lncRNAs (long noncoding RNAs) are …
Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral …
Y Yang, D Chen, H Liu, K Yang - Cell Death & Disease, 2019 - nature.com
Recent studies showed that lncRNA CASC9 was upregulated and acted as an oncogene in
a variety of tumors. However, the expression and biological functions of CASC9 in oral …
a variety of tumors. However, the expression and biological functions of CASC9 in oral …
LncRNA IFITM4P promotes immune escape by up-regulating PD-L1 via dual mechanism in oral carcinogenesis
L Shi, Y Yang, M Li, C Li, Z Zhou, G Tang, L Wu, Y Yao… - Molecular Therapy, 2022 - cell.com
Oral squamous cell carcinoma (OSCC), which is typically preceded by oral leukoplakia (OL),
is a common malignancy with poor prognosis. However, the signaling molecules governing …
is a common malignancy with poor prognosis. However, the signaling molecules governing …
Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis
H Tang, Z Wu, J Zhang, B Su - Molecular medicine …, 2013 - spandidos-publications.com
Oral squamous cell carcinoma (OSCC) is a common and lethal malignancy. Thus,
improvement in current knowledge of molecular changes associated with OSCC is urgently …
improvement in current knowledge of molecular changes associated with OSCC is urgently …
Long non-coding RNAs: challenges for diagnosis and therapies
Y Sánchez, M Huarte - Nucleic acid therapeutics, 2013 - liebertpub.com
Long non-coding RNAs (lncRNAs) have emerged as one of the largest and more diverse
classes of cellular transcripts. The growing evidence suggests that lncRNAs are key …
classes of cellular transcripts. The growing evidence suggests that lncRNAs are key …
Long noncoding RNAs as new architects in cancer epigenetics, prognostic biomarkers, and potential therapeutic targets
D Meseure, K Drak Alsibai, A Nicolas… - BioMed research …, 2015 - Wiley Online Library
Recent advances in genome‐wide analysis have revealed that 66% of the genome is
actively transcribed into noncoding RNAs (ncRNAs) while less than 2% of the sequences …
actively transcribed into noncoding RNAs (ncRNAs) while less than 2% of the sequences …
[HTML][HTML] Long non-coding RNAs in colorectal cancer
X Xie, B Tang, YF Xiao, R Xie, BS Li, H Dong, JY Zhou… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide.
Despite substantial progress in understanding the molecular mechanisms and treatment of …
Despite substantial progress in understanding the molecular mechanisms and treatment of …
Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis
Z Fang, L Wu, L Wang, Y Yang, Y Meng… - Oral surgery, oral …, 2014 - Elsevier
Objective The aim of this study was to examine the expression of several cancer-related
long non-coding RNAs (lncRNAs) in patients with tongue squamous cell carcinoma (TSCC) …
long non-coding RNAs (lncRNAs) in patients with tongue squamous cell carcinoma (TSCC) …
Influence of microRNAs and long non-coding RNAs in cancer chemoresistance
D Ayers, J Vandesompele - Genes, 2017 - mdpi.com
Innate and acquired chemoresistance exhibited by most tumours exposed to conventional
chemotherapeutic agents account for the majority of relapse cases in cancer patients. Such …
chemotherapeutic agents account for the majority of relapse cases in cancer patients. Such …